Dr. Reddy's Laboratories
RDY
#1699
Rank
HK$92.39 B
Marketcap
HK$110.46
Share price
0.35%
Change (1 day)
-1.28%
Change (1 year)

Dr. Reddy's Laboratories (RDY) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : HK$15.76 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company's total liabilities are HK$15.76 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Dr. Reddy's Laboratories - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-03-31HK$14.18 B41.25%
2024-03-31HK$10.04 B15.66%
2023-03-31HK$8.68 B-17.76%
2022-03-31HK$10.55 B7.54%
2021-03-31HK$9.81 B23.47%
2020-03-31HK$7.95 B-17.49%
2019-03-31HK$9.63 B-19.38%
2018-03-31HK$11.95 B4.15%
2017-03-31HK$11.47 B23.58%
2016-03-31HK$9.28 B-10.58%
2015-03-31HK$10.38 B1.13%
2014-03-31HK$10.26 B3.21%
2013-03-31HK$9.94 B5.03%
2012-03-31HK$9.47 B10.45%
2011-03-31HK$8.57 B31.65%
2010-03-31HK$6.51 B1.78%
2009-03-31HK$6.40 B-13.89%
2008-03-31HK$7.43 B-7.56%
2007-03-31HK$8.04 B-0.74%
2006-03-31HK$8.10 B442.22%
2005-03-31HK$1.49 B48.84%
2004-03-31HK$1.00 B44.1%
2003-03-31HK$0.69 B24.36%
2002-03-31HK$0.56 B-49.26%
2001-03-31HK$1.10 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
HK$900.17 B 5,609.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$253.79 B 1,509.79%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
HK$477.07 B 2,926.05%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
HK$486.82 B 2,987.90%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
HK$513.99 B 3,160.23%๐Ÿ‡ซ๐Ÿ‡ท France